Search results for “Breast cancer metastasis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 148 patents, we discovered top 56 key players by total patent application. OncoTherapy Science, Inc., Human Genome Sciences, Inc., Celera Corp. are dominant in this area. They take 35.14% of the total patent filing.
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 21
Human Genome Sciences, Inc.
United States
Patent: 16
Celera Corp.
California, United States
Patent: 10
Veridex LLC
New Jersey, United States
Patent: 8
Orion Corp
South Korea
Patent: 6
Sysmex Corp.
Hokkaido, Japan
Patent: 5
Applera Corp.
Connecticut, United States
Patent: 4
PharmAbcine Inc.
South Korea
Patent: 3
Immunomedics, Inc.
New Jersey, United States
Patent: 3
Jiangsu Weizhen Biomedical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 98 patents applied in the last 5 years. We discover 66 most active companies in this area. The fast-growing Seoul University Industry Academic Cooperation Foundation, Academia Sinica, MSD International GmbH take 11.22% of patent filing during this period.
Seoul University Industry Academic Cooperation Foundation
South Korea
Patent: 4
Academia Sinica
China
Patent: 4
MSD International GmbH
Singapore
Patent: 3
PharmAbcine Inc.
South Korea
Patent: 3
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 3
Jiangmen Central Hospital
undefined undefined
Patent: 3
Fudan University Cancer Hospital
Guangdong Sheng, China
Patent: 3
Soochow University
Jiangsu Sheng, China
Patent: 2
Industry-University Cooperation Foundation Hanyang University
South Korea
Patent: 2
Institute of Basic Medical Sciences
Beijing Shi, China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 98 patents in last 5 years, we discover 52 new entrants. MSD International GmbH, PharmAbcine Inc., Merck Sharp & Dohme BV are the most active new entrants in this area.
MSD International GmbH
Singapore
Patent: 3
PharmAbcine Inc.
South Korea
Patent: 3
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 3
Jiangmen Central Hospital
undefined undefined
Patent: 3
Industry-University Cooperation Foundation Hanyang University
South Korea
Patent: 2
Institute of Basic Medical Sciences
Beijing Shi, China
Patent: 2
University of Miami
United States
Patent: 2
Fudan University
Shanghai Shi, China
Patent: 2
Peking University Shenzhen Hospital
China
Patent: 2
Xinxiang Medical University
Henan Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 204 patents, we discovered top 47 universities and scientific research institutions by total patent application. Nankai University, The University of Liverpool, National University of Singapore are dominant in this area. They take 12.25% of the total patent filing.
Nankai University
Tianjin Shi, China
Patent: 9
The University of Liverpool
CITY OF LIVERPOOL, United Kingdom
Patent: 6
National University of Singapore
Central Region, Singapore
Patent: 4
University of Tokyo
Tokyo-to, Japan
Patent: 4
University of Freiburg
Baden-Württemberg, Germany
Patent: 4
Tianjin Medical University
Tianjin Shi, China
Patent: 3
Royal College of Surgeons
Ireland
Patent: 3
Soochow University
Jiangsu Sheng, China
Patent: 3
University of Miami
United States
Patent: 2
Fudan University
Shanghai Shi, China
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: